ALGN Align Technology, Inc. - Common Stock
NASDAQ · Health Care · Wyświetl na SEC EDGAR ↗ 10-K/10-Q Sie 5, 2026ALGN Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
ALGN Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Align Technology, Inc. - Common Stock Przegląd firmy z Wikipedii
Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
Invisalign
Invisalign is a brand of clear aligners manufactured by Align Technology. The clear align system had been used to treat more than 18 million patients by 2017, and 22 million patients by 2026.
Align Technology founder Zia Chishti conceived of the basic design of Invisalign while an adult orthodontics patient. During his treatment with a retainer intended to complete his treatment, he posited that a series of such devices could effect a large final placement in a series of small movements. He partnered with Kelsey Wirth to seek developers.
Invisalign was approved by the Food and Drug Administration in 1998, and sales began in the U.S. in 1999. Orthodontists were resistant to adopting Invisalign at first, in particular because the founders had no orthodontic credentials or expertise, but the product became popular among consumers. The company raised about $140 million in funding over four rounds from 1997 to 2000. In 2000 Align Technology planned a $31 million television advertising campaign that The New York Times said would be "the most aggressive consumer advertising plan the dental profession has ever seen". In 2001, $130 million in additional funding was raised through an initial public offering on NASDAQ. By 2001, 75 percent of the 8,500 orthodontists in North America had been trained on the Invisalign system. That same year, Align Technology made Invisalign available to general dentists following a class-action lawsuit that alleged making the system available only to orthodontists resulted in unfair competition for dentists.
In the early 2000s, Align Technology was spending nearly all of its revenues on marketing and advertising, and losing about $18 million per year. Cofounders Wirth and Chishti resigned from Align Technology in 2001 and 2003 respectively, with Thomas Prescott replacing Chishti as CEO in March 2002. Prescott re-focused the company on North America and cut the marketing budget to about one-third its original size.
The Invisalign system grew from 80,000 patients in 2002 to 175,000 in 2004. It won several awards for stereolithography, medical design and fast growth. Align Technology was profitable for the first time in 2003. In 2005 the company expanded into Japan, and acquired General Orthodontic, an orthodontics firm that supported doctors prescribing the Invisalign system. Later that year, the Harvard School of Dental Medicine began requiring that its orthodontic graduate students complete Invisalign certification before they graduate.
The Invisalign Express 10, which uses 10 aligners, was introduced in 2005. Invisalign 1.5 was released in 2009. It was followed by Invisalign G3 in 2010 and G4 in 2011. Invisalign G3 and G4 were designed for more complex treatments. An Invisalign Express 5 version, which uses 5 aligners, was introduced in 2012. In February 2014, Align Technology released a G5 product designed to treat deep bites.
Support, software engineering, pre-production and administrative functions are done from Align Technology's headquarters in California. The manufacturing of Invisalign aligners is performed in Mexico, and treatment plans are created in Costa Rica. Align Technology also operates separate subsidiaries in Hong Kong and Australia that sell Invisalign in their respective markets. Align Technology provides training and certification to doctors.
In 2007 the Academy of General Dentistry approved Align Technology's Program Approval for Continuing Education (PACE) program. The company also created the AlignTech Institute, which provides educational resources to doctors. In March 2011 Align Technology acquired Cadent System, Inc., a dentist firm, for $190 million.
A major revision to the manufacturing process was started in 2026, a switch from mold-based appliance manufacture to 3D-printing, aimed at reducing the cost and complexity of the manufacturing process through disintermediation.
History
Align Technology was founded in 1997 by Zia Chishti and Kelsey Wirth, classmates at Stanford Graduate School of Business, and began working on the development of a clear aligner. Align received FDA clearance to market the Invisalign system in 1998, and it was first marketed in 2000. Align Technology went public on January 26, 2001, on the Nasdaq Stock Market.
In March 2011 Align acquired the Israeli company Cadent for $190 million; Cadent manufactured intraoral scanners that included 3D imaging, as well as software to display the acquired images and to plan treatment.
Joseph M. Hogan joined Align in June 2015, and is CEO and president.
The company's sales reached $1 billion for the first time in 2016 and its products were being used in about 8% of people who got braces. In 2017 the company was faced with the challenge of the expiration of its patents on its Invisalign system starting in October 2017 and the beginning of generic competition.
In March 2020, Align Technology announced that it has signed a definitive agreement to acquire exocad Global Holdings for approximately $418.7 million.
As of February 2023, Align Technology has assisted over 234,000 doctors and over 14.5 million patients worldwide.
In September 2023, it was announced Align Technology had acquired the Vienna-headquartered 3D printing technology and materials company, Cubicure GmbH.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ALGN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 26.9średnia z 5 lat ≈45.1 | ≈45.1 | 28.5 | Zawyżona wycena | |
| P/S (TTM) | 2.7średnia z 5 lat ≈5.9 | ≈5.9 | 2.6 | Zawyżona wycena | |
| P/B (MRQ) | 2.6średnia z 5 lat ≈6.2 | ≈6.2 | 2.1 | Zawyżona wycena | |
| Cena / FCF (TTM) | 17.4średnia z 5 lat ≈41.4 | ≈41.4 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 14.6średnia z 5 lat ≈27.7 | ≈27.7 | 18.8 | Wartość godziwa | |
| Cena / Wartość księgowa materialna (MRQ) | 2.7średnia z 5 lat ≈7.3 | ≈7.3 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ALGN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 68.0%średnia z 5 lat ≈70.4% | ≈70.4% | 58.2% | Najwyższa półka | |
| Marża Operacyjna (TTM) | 13.2%średnia z 5 lat ≈17.5% | ≈17.5% | 11.3% | Najwyższa półka | |
| Marża EBITDA (TTM) | 19.4%średnia z 5 lat ≈21.3% | ≈21.3% | 16.0% | Zgodnie z | |
| Marża przed opodatkowaniem (TTM) | 13.7%średnia z 5 lat ≈17.6% | ≈17.6% | 8.6% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 10.0%średnia z 5 lat ≈12.3% | ≈12.3% | 6.7% | Najwyższa półka | |
| ROA (TTM) | 6.5%średnia z 5 lat ≈8.2% | ≈8.2% | 3.5% | Najwyższa półka | |
| ROE (TTM) | 10.2%średnia z 5 lat ≈12.9% | ≈12.9% | 6.5% | Najwyższa półka | |
| ROIC | 9.4%średnia z 5 lat ≈12.8% | ≈12.8% | 5.1% | Najwyższa półka |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ALGN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.4średnia z 5 lat ≈1.3 | ≈1.3 | 2.1 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 1.1średnia z 5 lat ≈1.0 | ≈1.0 | 0.8 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ALGN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 0.90%średnia z 5 lat ≈12.4% | ≈12.4% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 2.6%średnia z 5 lat ≈6.3% | ≈6.3% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 10.3% | · | · | · | |
| EPS YoY | 0.53%średnia z 5 lat ≈-17.2% | ≈-17.2% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -2.6%średnia z 5 lat ≈-18.9% | ≈-18.9% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 7.0%średnia z 5 lat ≈-15.3% | ≈-15.3% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -24.1% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 4.3%średnia z 5 lat ≈-17.0% | ≈-17.0% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -25.4% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ALGN | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.6średnia z 5 lat ≈0.7 | ≈0.7 | 0.6 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 5.5średnia z 5 lat ≈4.6 | ≈4.6 | 2.6 | Najwyższa półka | |
| Receivables Turnover (Rotacja należności) | 3.8średnia z 5 lat ≈4.4 | ≈4.4 | 7.0 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$197.5K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 29, 2026 | $2.64 | $2.66 | -0.87% |
| 31 marca 2026 | $2.58 | $2.33 | 11.0% | |
| 31 grudnia 2025 | $3.29 | $3.03 | 8.5% | |
| 30 września 2025 | $2.61 | $2.45 | 6.5% | |
| 30 czerwca 2025 | $2.49 | $2.62 | -5.0% | |
| 31 marca 2025 | $2.13 | $2.02 | 5.2% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Cost of Revenue | $1.32B | $1.20B | $1.16B | $1.10B | $1.02B | $709M | $663M | $519M | $356M | $265M | $205M | $183M | |
| Gross Profit | $2.71B | $2.80B | $2.71B | $2.63B | $2.94B | $1.76B | $1.74B | $1.45B | $1.12B | $815M | $640M | $578M | |
| R&D Expense | $370M | $364M | $347M | $305M | $250M | $175M | $157M | $129M | $98M | $76M | $61M | $53M | |
| SG&A Expense | $1.76B | $1.76B | $1.70B | $1.67B | $1.71B | $1.20B | $1.07B | $852M | · | · | $390M | $332M | |
| Operating Expenses | $2.17B | $2.19B | $2.06B | $1.99B | $1.96B | $1.38B | $1.20B | $981M | $763M | $566M | $451M | $385M | |
| Operating Income | $546M | $608M | $643M | $643M | $976M | $387M | $542M | $467M | $354M | $249M | $189M | $194M | |
| Interest Income | · | · | · | · | · | · | $12M | $9M | $7M | $4M | · | · | |
| Other Non-op | $23M | $-19M | $-19M | $-49M | $33M | $-11M | $8M | $-8M | $4M | $-11M | $-3M | $-3M | |
| Pretax Income | $585M | $609M | $641M | $599M | $1.01B | $379M | $563M | $467M | $365M | $243M | $186M | $190M | |
| Income Tax | $175M | $188M | $196M | $237M | $240M | $-1.40B | $112M | $58M | $130M | $51M | $42M | $45M | |
| Net Income | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| EPS (Basic) | $5.66 | $5.63 | $5.82 | $4.62 | $9.78 | $22.55 | $5.57 | $5.00 | $2.89 | $2.38 | $1.80 | $1.81 | |
| EPS (Diluted) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 | |
| Shares (Basic) | 72,542,000 | 74,877,000 | 76,426,000 | 78,190,000 | 78,917,000 | 78,760,000 | 79,424,000 | 80,064,000 | 80,085,000 | 79,856,000 | 79,998,000 | 80,754,000 | |
| Shares (Diluted) | 72,588,000 | 74,993,000 | 76,568,000 | 78,420,000 | 79,670,000 | 79,230,000 | 80,100,000 | 81,357,000 | 81,832,000 | 81,484,000 | 81,521,000 | 82,283,000 | |
| EBITDA | $783M | $753M | $786M | $768M | $1.09B | $481M | $621M | $521M | $391M | $273M | $207M | $211M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.09B | $1.04B | $937M | $942M | $1.10B | $961M | $550M | $637M | $450M | $389M | $168M | $200M | |
| Short-term Investments | · | · | · | · | · | · | $318M | $98M | $272M | $251M | $360M | $255M | |
| Receivables | $1.10B | $996M | $903M | $860M | $897M | $658M | $550M | $439M | $324M | $247M | $159M | $130M | |
| Inventory | $226M | $254M | $297M | $339M | $230M | $139M | $112M | $56M | $32M | $27M | $19M | $16M | |
| Prepaid Expense | $166M | $199M | $274M | $226M | $195M | $92M | $102M | $72M | $81M | $38M | $27M | $20M | |
| Other Current Assets | $47M | $82M | $77M | $17M | $31M | $62M | $24M | $7M | · | · | · | · | |
| Current Assets | $2.62B | $2.49B | $2.45B | $2.42B | $2.49B | $1.85B | $1.63B | $1.30B | $1.16B | $953M | $732M | $657M | |
| PP&E (Net) | $1.13B | $1.27B | $1.29B | $1.23B | $1.08B | $735M | $632M | $521M | $349M | $175M | $136M | $90M | |
| PP&E (Gross) | $1.90B | $1.93B | $1.84B | $1.68B | $1.44B | $1.04B | $861M | $693M | $485M | $311M | $255M | $198M | |
| Accum. Depreciation | $767M | $662M | $551M | $450M | $359M | $301M | $230M | $172M | $136M | $136M | $118M | $108M | |
| Goodwill | $492M | $443M | $420M | $408M | $419M | $445M | $64M | $64M | $65M | $61M | $61M | $61M | |
| Intangibles | $94M | $103M | $82M | $96M | $110M | $130M | $12M | $18M | $24M | $21M | $18M | $21M | |
| Other Non-current Assets | $278M | $234M | $129M | $56M | $58M | $35M | $40M | $27M | $44M | $13M | $8M | $8M | |
| Total Assets | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Accounts Payable | $121M | $109M | $113M | $128M | $164M | $142M | $87M | $64M | $37M | $29M | $34M | $23M | |
| Accrued Liabilities | $537M | $598M | $526M | $454M | $607M | $406M | $320M | $235M | $196M | $134M | $108M | $88M | |
| Current Liabilities | $1.92B | $2.04B | $2.07B | $1.93B | $1.92B | $1.33B | $971M | $692M | $500M | $354M | $272M | $202M | |
| Capital Leases | $83M | $88M | $97M | $100M | $103M | $64M | $43M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $114M | $140M | $173M | $196M | $175M | $100M | $37M | $29M | $16M | $1M | $2M | $3M | |
| Total Liabilities | $2.18B | $2.36B | $2.45B | $2.35B | $2.32B | $1.60B | $1.15B | $800M | $630M | $401M | $311M | $235M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | |
| Paid-in Capital | $1.51B | $1.36B | $1.16B | $1.04B | $999M | $975M | $907M | $878M | $886M | $865M | $822M | $783M | |
| Retained Earnings | $2.46B | $2.48B | $2.45B | $2.57B | $2.62B | $2.22B | $440M | $378M | $267M | $131M | $27M | $-31M | |
| AOCI | $75M | $6M | $21M | $-10M | $4M | $44M | $-688.0K | $-3M | $571.0K | $-938.0K | $-980.0K | $-140.0K | |
| Stockholders' Equity | $4.05B | $3.85B | $3.63B | $3.60B | $3.62B | $3.23B | $1.35B | $1.25B | $1.15B | $999M | $848M | $753M | |
| Liabilities + Equity | $6.23B | $6.21B | $6.08B | $5.95B | $5.94B | $4.83B | $2.50B | $2.05B | $1.78B | $1.40B | $1.16B | $988M | |
| Shares Outstanding | 71,364,000 | 73,849,000 | 75,075,000 | 77,267,000 | 78,710,000 | 78,860,000 | 78,433,000 | 79,778,000 | 80,040,000 | 79,553,000 | 79,500,000 | 80,205,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $237M | $145M | $142M | $126M | $109M | $94M | $79M | $55M | $38M | $24M | $18M | $18M | |
| Stock-based Comp | $186M | $174M | $154M | $133M | $114M | $98M | $88M | $71M | $59M | $54M | $53M | $40M | |
| Deferred Tax | $33M | $26M | $-19M | $-39M | $15M | $-1.49B | $307.0K | $-16M | $18M | $-16M | $-11M | $4M | |
| Amort. of Intangibles | $19M | $19M | $16M | $16M | $17M | $13M | $6M | $6M | $6M | $3M | · | · | |
| Restructuring | · | $37M | $14M | $10M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-274M | $-28M | $63M | $-13M | $162M | $186M | $137M | $45M | $93M | $-4M | $34M | $-2M | |
| Operating Cash Flow | $593M | $738M | $786M | $569M | $1.17B | $662M | $747M | $555M | $439M | $248M | $238M | $227M | |
| CapEx | $102M | $116M | $178M | $292M | $401M | $155M | $150M | $223M | $196M | $71M | $53M | $24M | |
| Investing Cash Flow | $-112M | $-255M | $-196M | $-213M | $-563M | $-232M | $-350M | $7M | $-251M | $73M | $-166M | $-202M | |
| Stock Issued | $22M | $25M | $27M | $26M | $26M | $20M | $18M | $17M | $14M | $14M | $11M | $18M | |
| Stock Repurchased | $466M | $353M | $592M | $435M | $375M | $0 | $400M | $300M | $104M | $96M | $102M | $98M | |
| Net Stock Activity | $-444M | $-328M | $-566M | $-409M | $-349M | $20M | $-382M | $-283M | $-89M | $-82M | $-90M | $-80M | |
| Financing Cash Flow | $-465M | $-356M | $-598M | $-502M | $-458M | $-31M | $-486M | $-369M | $-136M | $-96M | $-101M | $-66M | |
| Net Change in Cash | $51M | $106M | $-4M | $-158M | $139M | $410M | $-86M | $187M | $57M | $222M | $-32M | $-43M | |
| Taxes Paid | $135M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $491M | $623M | $608M | $277M | $771M | $507M | $598M | $331M | $243M | $177M | $185M | $203M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% | 71.3% | 72.5% | 73.6% | 75.8% | 75.5% | 75.7% | 75.9% | |
| Operating Margin | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% | 15.7% | 22.5% | 23.7% | 24.0% | 23.1% | 22.3% | 25.4% | |
| Net Margin | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% | 17.0% | 19.1% | |
| Pretax Margin | 14.5% | 15.2% | 16.6% | 16.0% | 25.6% | 15.3% | 23.4% | 23.7% | 24.8% | 22.5% | 22.0% | 25.0% | |
| EBITDA Margin | 19.4% | 18.8% | 20.3% | 20.6% | 27.5% | 19.4% | 25.8% | 26.5% | 26.6% | 25.3% | 24.4% | 27.8% | |
| ROA | 6.6% | 6.9% | 7.4% | 6.1% | 14.3% | 48.4% | 19.4% | 20.9% | 14.6% | 14.8% | 13.4% | 16.0% | |
| ROE | 10.3% | 10.8% | 12.0% | 9.9% | 21.6% | 56.7% | 33.4% | 32.7% | 21.5% | 20.6% | 18.0% | 21.0% | |
| ROIC | 9.4% | 10.9% | 12.3% | 10.8% | 20.5% | 56.1% | 32.2% | 32.6% | 19.8% | 19.7% | 17.2% | 19.7% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.7 | 1.9 | 2.3 | 2.7 | 2.7 | 3.3 | |
| Quick Ratio | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 | 1.2 | 1.5 | 1.7 | 2.1 | 2.5 | 2.5 | 2.9 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | |
| Inventory Turnover | 5.5 | 4.4 | 3.6 | 3.9 | 5.5 | 5.6 | 7.9 | 11.9 | 12.1 | 11.4 | 11.6 | 12.3 | |
| Receivables Turnover | 3.8 | 4.2 | 4.4 | 4.3 | 5.1 | 4.1 | 4.9 | 5.2 | 5.2 | 5.3 | 5.9 | 6.3 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $56.74 | $52.16 | $48.36 | $46.61 | $46.03 | $41.01 | $17.16 | $15.70 | $14.37 | $12.51 | $10.67 | $9.39 | |
| Revenue / Share | $55.59 | $53.33 | $50.44 | $47.62 | $49.61 | $31.20 | $30.05 | $24.17 | $18.01 | $13.25 | $10.37 | $9.26 | |
| Cash Flow / Share | $8.17 | $9.84 | $10.26 | $7.25 | $14.72 | $8.36 | $9.33 | $6.82 | $5.36 | $3.04 | $2.92 | $2.76 | |
| Cash / Share | $15.34 | $14.14 | $12.49 | $12.19 | $13.97 | $12.18 | $7.02 | $7.98 | $5.62 | $4.89 | $2.11 | $2.49 | |
| EPS (TTM) | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 | $1.77 | $1.77 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.90% | 3.5% | 3.4% | -5.5% | 59.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.6% | 0.39% | 16.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 0.53% | -3.3% | 26.0% | -52.4% | -56.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 7.0% | -16.6% | -36.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -24.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -2.6% | -5.3% | 23.1% | -53.2% | -56.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 4.3% | -18.3% | -37.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -25.4% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B | $2.47B | $2.41B | $1.97B | $1.47B | $1.08B | $845M | $762M | |
| Net Income TTM | $410M | $421M | $445M | $362M | $772M | $1.78B | $443M | $400M | $231M | $190M | $144M | $146M | |
| Market Cap | $11.14B | $15.40B | $20.57B | $16.30B | $51.73B | $42.14B | $21.89B | $16.71B | $17.78B | $7.65B | $5.24B | $4.48B | |
| P/E | 27.6 | 37.1 | 47.2 | 45.7 | 67.8 | 23.8 | 50.5 | 42.6 | 78.5 | 41.3 | 37.2 | 31.6 | |
| P/S | 2.8 | 3.9 | 5.3 | 4.4 | 13.1 | 17.0 | 9.1 | 8.5 | 12.1 | 7.1 | 6.2 | 5.9 | |
| P/B | 2.8 | 4.0 | 5.7 | 4.5 | 14.3 | 13.0 | 16.3 | 13.3 | 15.5 | 7.7 | 6.2 | 6.0 | |
| P / Tangible Book | 3.2 | 4.7 | 6.6 | 5.3 | 16.7 | 15.8 | · | · | · | · | · | · | |
| P / Cash Flow | 18.8 | 20.9 | 26.2 | 28.7 | 44.1 | 63.6 | 29.3 | 30.1 | 40.6 | 30.9 | 22.0 | 19.8 | |
| P / FCF | 22.7 | 24.7 | 33.8 | 58.9 | 67.1 | 83.1 | 36.6 | 50.4 | 73.2 | 43.2 | 28.4 | 22.1 | |
| Earnings Yield | 3.6% | 2.7% | 2.1% | 2.2% | 1.5% | 4.2% | 2.0% | 2.4% | 1.3% | 2.4% | 2.7% | 3.2% |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.04B | $1.05B | $996M | $1.01B | $979M | $995M | $978M | $1.03B | $997M | $957M | $960M | $1.00B | $943M | $902M | $890M | |
| Cost of Revenue | $299M | $304M | $364M | $356M | $304M | $299M | $298M | $296M | $306M | $300M | $287M | $297M | $289M | $282M | $284M | $271M | |
| Gross Profit | $757M | $737M | $684M | $639M | $708M | $680M | $697M | $682M | $723M | $698M | $670M | $663M | $714M | $661M | $618M | $619M | |
| R&D Expense | $102M | $99M | $83M | $93M | $96M | $97M | $95M | $85M | $92M | $92M | $82M | $89M | $88M | $87M | $84M | $77M | |
| SG&A Expense | $463M | $465M | $442M | $418M | $449M | $448M | $425M | $434M | $452M | $452M | $403M | $408M | $453M | $440M | $410M | $399M | |
| Operating Expenses | $603M | $595M | $528M | $543M | $545M | $549M | $553M | $519M | $576M | $544M | $498M | $497M | $542M | $527M | $505M | $476M | |
| Operating Income | $154M | $142M | $155M | $96M | $163M | $131M | $144M | $162M | $147M | $154M | $172M | $166M | $172M | $134M | $113M | $144M | |
| Other Non-op | $-10M | $3M | $17M | $-5M | $8M | $4M | $-12M | $-371.0K | $-6M | $-141.0K | $-4M | $-10M | $-5M | $-1M | $-100.0K | $-23M | |
| Pretax Income | $149M | $149M | $177M | $95M | $174M | $140M | $141M | $166M | $144M | $158M | $173M | $162M | $172M | $135M | $115M | $123M | |
| Income Tax | $40M | $36M | $41M | $38M | $49M | $47M | $37M | $50M | $47M | $53M | $49M | $41M | $60M | $47M | $74M | $50M | |
| Net Income | $108M | $113M | $136M | $57M | $125M | $93M | $104M | $116M | $97M | $105M | $124M | $121M | $112M | $88M | $42M | $73M | |
| EPS (Basic) | $1.51 | $1.58 | $1.89 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.40 | $1.63 | $1.59 | $1.46 | $1.14 | $0.54 | $0.93 | |
| EPS (Diluted) | $1.51 | $1.57 | $1.88 | $0.78 | $1.72 | $1.27 | $1.40 | $1.55 | $1.28 | $1.39 | $1.63 | $1.58 | $1.46 | $1.14 | $0.54 | $0.93 | |
| Shares (Basic) | 71,495,000 | 71,425,000 | · | 72,377,000 | 72,565,000 | 73,562,000 | · | 74,736,000 | 75,184,000 | 75,175,000 | · | 76,569,000 | 76,524,000 | 76,921,000 | · | 78,093,000 | |
| Shares (Diluted) | 71,520,000 | 71,614,000 | · | 72,419,000 | 72,593,000 | 73,615,000 | · | 74,757,000 | 75,223,000 | 75,322,000 | · | 76,826,000 | 76,689,000 | 77,111,000 | · | 78,237,000 | |
| EBITDA | $194M | $199M | · | $152M | $204M | $170M | · | $200M | $183M | $187M | · | $203M | $208M | $169M | · | $176M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.06B | $1.09B | $1.00B | $901M | $873M | $1.04B | $1.04B | $761M | $866M | · | $1.24B | $952M | $832M | · | $1.04B | |
| Receivables | $1.15B | $1.13B | $1.10B | $1.10B | $1.12B | $1.06B | $996M | $1.01B | $1.02B | $951M | · | $904M | $908M | $884M | · | $860M | |
| Inventory | $212M | $215M | $226M | $228M | $244M | $247M | $254M | $254M | $259M | $280M | · | $296M | $313M | $312M | · | $321M | |
| Prepaid Expense | $200M | $216M | $166M | $174M | $187M | $220M | $199M | $291M | $351M | $350M | · | $218M | $237M | $252M | · | $229M | |
| Other Current Assets | $52M | $57M | $47M | $57M | $57M | $83M | $82M | $69M | $71M | $70M | · | $34M | $23M | $23M | · | $47M | |
| Current Assets | $2.66B | $2.66B | $2.62B | $2.53B | $2.45B | $2.40B | $2.49B | $2.60B | $2.41B | $2.48B | · | $2.70B | $2.47B | $2.33B | · | $2.50B | |
| PP&E (Net) | $1.11B | $1.11B | $1.13B | $1.18B | $1.26B | $1.26B | $1.27B | $1.29B | $1.28B | $1.28B | · | $1.27B | $1.28B | $1.26B | · | $1.20B | |
| PP&E (Gross) | · | · | $1.90B | · | · | · | $1.93B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $767M | · | · | · | $662M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $497M | $503M | $492M | $492M | $491M | $458M | $443M | $472M | $454M | $458M | $420M | $404M | $415M | $414M | $408M | $378M | |
| Intangibles | $95M | $101M | $94M | $99M | $103M | $103M | $103M | $116M | $116M | $121M | · | $83M | $89M | $93M | · | $92M | |
| Other Non-current Assets | $453M | $365M | $278M | $254M | $251M | $239M | $234M | $200M | $198M | $122M | · | $132M | $138M | $54M | · | $52M | |
| Total Assets | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Accounts Payable | $110M | $124M | $121M | $126M | $114M | $125M | $109M | $109M | $106M | $117M | · | $100M | $110M | $131M | · | $139M | |
| Accrued Liabilities | $612M | $547M | $537M | $546M | $563M | $546M | $598M | $575M | $555M | $497M | · | $614M | $600M | $497M | · | $384M | |
| Current Liabilities | $1.91B | $1.91B | $1.92B | $1.97B | $2.00B | $1.99B | $2.04B | $2.06B | $2.04B | $2.02B | · | $2.12B | $2.11B | $2.00B | · | $1.81B | |
| Capital Leases | $87M | $83M | $83M | $87M | $90M | $86M | $88M | $96M | $98M | $95M | · | $99M | $105M | $99M | · | $97M | |
| Other Non-current Liabilities | $120M | $108M | $114M | $112M | $117M | $131M | $140M | $150M | $158M | $156M | · | $179M | $181M | $191M | · | $185M | |
| Total Liabilities | $2.19B | $2.16B | $2.18B | $2.28B | $2.31B | $2.31B | $2.36B | $2.42B | $2.40B | $2.40B | · | $2.52B | $2.51B | $2.42B | · | $2.22B | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Paid-in Capital | $1.57B | $1.53B | $1.51B | $1.48B | $1.43B | $1.39B | $1.36B | $1.34B | $1.28B | $1.24B | · | $1.19B | $1.14B | $1.10B | · | $1.06B | |
| Retained Earnings | $2.60B | $2.55B | $2.46B | $2.42B | $2.43B | $2.39B | $2.48B | $2.57B | $2.46B | $2.50B | · | $2.61B | $2.49B | $2.37B | · | $2.67B | |
| AOCI | $67M | $70M | $75M | $65M | $61M | $18M | $6M | $36M | $25M | $18M | · | $2M | $11M | $2M | · | $-41M | |
| Stockholders' Equity | $4.23B | $4.15B | $4.05B | $3.96B | $3.91B | $3.79B | $3.85B | $3.94B | $3.76B | $3.76B | $3.63B | $3.80B | $3.64B | $3.48B | $3.60B | $3.69B | |
| Liabilities + Equity | $6.42B | $6.31B | $6.23B | $6.23B | $6.22B | $6.10B | $6.21B | $6.37B | $6.16B | $6.16B | · | $6.32B | $6.14B | $5.90B | · | $5.91B | |
| Shares Outstanding | 71,245,000 | 71,617,000 | 71,364,000 | 72,040,000 | 72,486,000 | 73,057,000 | 73,849,000 | 74,757,000 | 74,696,000 | 75,281,000 | · | 76,588,000 | 76,532,000 | 76,516,000 | · | 78,111,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $57M | $102M | $56M | $41M | $39M | $38M | $38M | $36M | $33M | $34M | $37M | $36M | $36M | $34M | $32M | |
| Stock-based Comp | $46M | $41M | $44M | $48M | $48M | $45M | $39M | $49M | $47M | $39M | $39M | $40M | $38M | $38M | $35M | $33M | |
| Deferred Tax | $-9M | $41M | $42M | $-9M | $-34M | $34M | $8M | $8M | $-9M | $18M | $4M | $14M | $-18M | $-18M | $-46M | $-8M | |
| Amort. of Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Restructuring | · | · | · | $32M | $-100.0K | $2M | $37M | $0 | $-357.0K | $14M | $14M | · | $100.0K | $10M | $10M | · | |
| Other Non-cash | · | $-100M | · | · | · | $-158M | · | · | · | $-166M | · | · | · | $57M | · | · | |
| Operating Cash Flow | $193M | $151M | $223M | $189M | $129M | $53M | $286M | $264M | $160M | $29M | $47M | $287M | $252M | $200M | $145M | $266M | |
| CapEx | $36M | $31M | $36M | $20M | $21M | $25M | $23M | $30M | $53M | $9M | $33M | $22M | $59M | $64M | $53M | $75M | |
| Investing Cash Flow | $-82M | $-132M | $-36M | $-20M | $-31M | $-25M | $-54M | $-9M | $-112M | $-80M | $-13M | $-4M | $-125M | $-53M | $-56M | $-85M | |
| Stock Issued | $0 | $12M | $0 | $8M | $0 | $14M | $0 | $11M | $0 | $14M | $0 | $12M | $0 | $14M | $0 | $11M | |
| Stock Repurchased | $67M | $31M | $97M | $72M | $96M | $201M | $203M | $0 | $150M | $0 | $300M | $0 | $0 | $292M | $160M | $0 | |
| Net Stock Activity | · | $-19M | · | · | · | $-187M | · | · | · | $14M | · | · | · | $-278M | · | · | |
| Financing Cash Flow | $-67M | $-48M | $-97M | $-64M | $-96M | $-207M | $-203M | $11M | $-152M | $-12M | $-350M | $12M | $-931.0K | $-259M | $-200M | $11M | |
| Net Change in Cash | $43M | $-35M | $90M | $103M | $28M | $-171M | $2M | $281M | $-104M | $-72M | $-301M | $287M | $120M | $-110M | $-102M | $167M | |
| Free Cash Flow | · | $120M | · | · | · | $27M | · | · | · | $19M | · | · | · | $136M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.7% | 70.8% | · | 64.2% | 69.9% | 69.5% | · | 69.7% | 70.3% | 70.0% | · | 69.1% | 71.2% | 70.0% | · | 69.5% | |
| Operating Margin | 14.6% | 13.7% | · | 9.7% | 16.1% | 13.4% | · | 16.6% | 14.3% | 15.4% | · | 17.3% | 17.2% | 14.2% | · | 16.1% | |
| Net Margin | 10.2% | 10.8% | · | 5.7% | 12.3% | 9.5% | · | 11.9% | 9.4% | 10.5% | · | 12.7% | 11.2% | 9.3% | · | 8.2% | |
| Pretax Margin | 14.1% | 14.3% | · | 9.5% | 17.1% | 14.3% | · | 17.0% | 14.0% | 15.9% | · | 16.9% | 17.1% | 14.3% | · | 13.8% | |
| EBITDA Margin | 18.4% | 19.1% | · | 15.3% | 20.1% | 17.4% | · | 20.5% | 17.8% | 18.8% | · | 21.2% | 20.7% | 17.9% | · | 19.8% | |
| ROA | 1.7% | 1.8% | · | 0.90% | 2.0% | 1.5% | · | 1.8% | 1.6% | 1.7% | · | 2.0% | 1.9% | 1.5% | · | 1.3% | |
| ROE | 2.7% | 2.8% | · | 1.4% | 3.2% | 2.5% | · | 3.0% | 2.6% | 2.9% | · | 3.2% | 3.1% | 2.5% | · | 2.0% | |
| ROIC | 2.6% | 2.6% | · | 1.5% | 3.0% | 2.3% | · | 2.9% | 2.6% | 2.7% | · | 3.3% | 3.1% | 2.5% | · | 2.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.0 | 0.9 | 0.9 | · | 1.0 | 0.9 | 0.9 | · | 1.1 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 1.3 | 1.3 | · | 1.5 | 1.2 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 | 0.9 | 1.0 | · | 1.0 | |
| Receivables Turnover | 0.9 | 1.0 | · | 0.9 | 0.9 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 1.0 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $59.41 | $57.94 | · | $54.93 | $53.98 | $51.94 | · | $52.76 | $50.31 | $49.94 | · | $49.64 | $47.54 | $45.48 | · | $47.30 | |
| Revenue / Share | $14.77 | $14.52 | · | $13.75 | $13.95 | $13.30 | · | $13.08 | $13.67 | $13.24 | · | $12.50 | $13.07 | $12.23 | · | $11.38 | |
| Cash Flow / Share | · | $2.11 | · | · | · | $0.72 | · | · | · | $0.38 | · | · | · | $2.59 | · | · | |
| Cash / Share | $15.48 | $14.80 | · | $13.94 | $12.43 | $11.95 | · | $13.94 | $10.19 | $11.50 | · | $16.18 | $12.44 | $10.88 | · | $13.37 | |
| EPS (TTM) | $5.74 | $5.95 | · | $5.17 | $5.94 | $5.50 | · | $5.85 | $5.88 | $6.06 | · | $4.72 | $4.07 | $4.05 | · | $6.46 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.14B | $4.10B | · | $3.98B | $3.96B | $3.98B | · | $3.96B | $3.94B | $3.92B | · | $3.81B | $3.74B | $3.70B | · | $3.86B | |
| Net Income TTM | $414M | $430M | · | $378M | $438M | $410M | · | $442M | $447M | $462M | · | $363M | $314M | $315M | · | $511M | |
| Market Cap | $12.02B | $12.28B | · | $9.02B | $13.72B | $11.61B | · | $19.01B | $18.03B | $24.69B | · | $23.38B | $27.06B | $25.57B | · | $16.18B | |
| P/E | 29.4 | 28.8 | · | 24.2 | 31.9 | 28.9 | · | 43.5 | 41.1 | 54.1 | · | 64.7 | 86.9 | 82.5 | · | 32.1 | |
| P/S | 2.9 | 3.0 | · | 2.3 | 3.5 | 2.9 | · | 4.8 | 4.6 | 6.3 | · | 6.1 | 7.2 | 6.9 | · | 4.2 | |
| P/B | 2.8 | 3.0 | · | 2.3 | 3.5 | 3.1 | · | 4.8 | 4.8 | 6.6 | · | 6.2 | 7.4 | 7.3 | · | 4.4 | |
| P / Tangible Book | 3.3 | 3.5 | · | 2.7 | 4.1 | 3.6 | · | 5.7 | 5.7 | 7.8 | · | 7.1 | 8.6 | 8.6 | · | 5.0 | |
| P / Cash Flow | · | 81.3 | · | · | · | 220.3 | · | · | · | 861.2 | · | · | · | 127.9 | · | · | |
| Earnings Yield | 3.4% | 3.5% | · | 4.1% | 3.1% | 3.5% | · | 2.3% | 2.4% | 1.8% | · | 1.6% | 1.1% | 1.2% | · | 3.1% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $4.03B | $4.00B | $3.86B | $3.73B | $3.95B |
| Marża Brutto % | 67.2% | 70.0% | 70.1% | 70.5% | 74.3% |
| Marża Operacyjna % | 13.5% | 15.2% | 16.7% | 17.2% | 24.7% |
| Zysk netto | $410M | $421M | $445M | $362M | $772M |
| Rozwodniony EPS | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.4 | 1.2 | 1.2 | 1.3 | 1.3 |
| Wskaźnik Szybkości | 1.1 | 1.0 | 0.9 | 0.9 | 1.0 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $491M | $623M | $608M | $277M | $771M |
Właściciele instytucjonalni (13F) 740 emitentów · $13.7B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 72 (-73 vs poprzedni kw.) | 81 (-3 vs poprzedni kw.) | 216 (-34 vs poprzedni kw.) | 290 (+62 vs poprzedni kw.) | +3.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 277 272 490 | 8 179 779 | 9,35% | Akcje |
| BlackRock, Inc. | $745 370 304 | 4 419 366 | 5,46% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $742 325 451 | 4 401 313 | 5,44% | Akcje |
| FMR LLC | $684 765 036 | 4 060 032 | 5,01% | Akcje |
| Capital International Investors | $682 324 318 | 4 045 561 | 5,00% | Akcje |
| Capital World Investors | $577 219 454 | 3 422 385 | 4,23% | Akcje |
| GOLDMAN SACHS GROUP INC | $568 849 702 | 3 372 760 | 4,17% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $528 203 316 | 3 131 764 | 3,87% | Akcje |
| STATE STREET CORP | $431 518 634 | 2 558 512 | 3,16% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $378 153 032 | 2 245 315 | 2,77% | Akcje |
| UBS Group AG | $358 450 738 | 2 125 286 | 2,63% | Akcje |
| Ninety One UK Ltd | $310 121 819 | 2 133 621 | 2,27% | Akcje |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $292 369 455 | 1 733 484 | 2,14% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $242 715 391 | 1 438 900 | 1,78% | Akcje |
| Invesco Ltd. | $238 412 210 | 1 413 567 | 1,75% | Akcje |
| Ruane, Cunniff & Goldfarb L.P. | $197 577 600 | 1 171 455 | 1,45% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $180 736 225 | 1 071 601 | 1,32% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $180 291 468 | 1 068 964 | 1,32% | Akcje |
| MORGAN STANLEY | $170 994 867 | 1 013 842 | 1,25% | Akcje |
| NORGES BANK | $152 573 715 | 904 623 | 1,12% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $151 163 848 | 899 731 | 1,11% | Akcje |
| Assenagon Asset Management S.A. | $140 248 651 | 964 903 | 1,03% | Akcje |
| JPMORGAN CHASE & CO | $134 654 324 | 773 182 | 0,99% | Akcje |
| DISCIPLINED GROWTH INVESTORS INC /MN | $132 090 801 | 783 178 | 0,97% | Akcje |
| Senvest Management, LLC | $125 709 888 | 745 345 | 0,92% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $112 686 638 | 668 129 | 0,83% | Akcje |
| Swedbank AB | $111 012 012 | 658 200 | 0,81% | Akcje |
| BARCLAYS PLC | $108 101 615 | 640 944 | 0,79% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $107 285 353 | 625 826 | 0,79% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $105 404 604 | 624 952 | 0,77% | Akcje |
| DEUTSCHE BANK AG\ | $99 778 582 | 591 596 | 0,73% | Akcje |
| NORTHERN TRUST CORP | $94 827 567 | 562 241 | 0,69% | Akcje |
| BANK OF AMERICA CORP /DE/ | $93 085 478 | 551 912 | 0,68% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $79 759 314 | 472 900 | 0,58% | Opcja sprzedaży |
| FEDERATED HERMES, INC. | $78 222 317 | 463 787 | 0,57% | Akcje |
| Bares Capital Management, Inc. | $76 349 389 | 609 722 | 0,56% | Akcje |
| Amundi | $73 309 080 | 434 656 | 0,54% | Akcje |
| BROWN ADVISORY INC | $69 759 715 | 413 611 | 0,51% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $63 304 170 | 375 336 | 0,46% | Akcje |
| JENNISON ASSOCIATES LLC | $59 641 380 | 353 619 | 0,44% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $59 357 000 | 351 934 | 0,43% | Akcje |
| Bank of New York Mellon Corp | $57 062 230 | 338 327 | 0,42% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56 163 780 | 333 000 | 0,41% | Opcja kupna |
| Carmignac Gestion | $53 495 676 | 316 832 | 0,39% | Akcje |
| CITADEL ADVISORS LLC | $50 443 170 | 299 082 | 0,37% | Akcje |
| Resona Asset Management Co.,Ltd. | $49 583 874 | 291 177 | 0,36% | Akcje |
| KEYBANK NATIONAL ASSOCIATION/OH | $47 572 414 | 282 061 | 0,35% | Akcje |
| WELLS FARGO & COMPANY/MN | $47 249 188 | 280 145 | 0,35% | Akcje |
| Nearwater Capital Markets, Ltd | $45 200 880 | 268 000 | 0,33% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $44 553 900 | 264 164 | 0,33% | Akcje |
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Danaher Corporation ×3 zgłoszenia | 14 listopada 2013 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
| 1. Danaher Corporation | 22 lutego 2011 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 66 insiderów · 24 dyrektorzy generalni · 17 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joseph M Hogan | President and CEO | 20 lutego 2026 M | 209 270 | 0 | 0 | $0 |
| John Morici | EVP, CHIEF FINANCIAL OFFICER | 20 lutego 2026 M | 13 536 | 0 | 1 | $-1 508 611 |
| Kenneth Arola | VP, Finance and CFO | 20 lutego 2013 C | 31 682 | 0 | 0 | $0 |
| Julie Ann Coletti | EVP, CHIEF LEGAL & REGULATORY | 20 lutego 2026 M | 11 445 | 0 | 0 | $0 |
| Stuart A Hockridge | EVP, GLOBAL HR | 20 lutego 2026 M | 14 892 | 0 | 0 | $0 |
| Emory Wright | EVP, GLOBAL OPERATIONS | 20 lutego 2024 A | 8 294 | 0 | 0 | $0 |
| Jennifer Olson | SVP & Mng Dir Cust Service | 6 listopada 2020 G | 2 277 | 0 | 0 | $0 |
| Yuval Shaked | SVP & Mng Dir. Itero | 4 listopada 2020 S | 636 | 0 | 0 | $0 |
| Zelko Relic | SVp, R&D and CTO | 4 listopada 2020 S | 13 716 | 0 | 0 | $0 |
| Markus Christof Sebstian | SVP & Mng Dir EMEA | 20 października 2020 M | 613 | 0 | 0 | $0 |
| Simon Beard | SVP and Mgng Director, EMEA | 27 sierpnia 2020 S | 17 670 | 0 | 0 | $0 |
| Vamsi Mohan Raj Pudipeddi | SVP, Chief Marketing Officer | 18 maja 2020 S | 0 | 0 | 0 | $0 |
| Sreelakshmi Kolli | SVP & Mng Dir Info Tech | 20 lutego 2020 M | 13 409 | 0 | 0 | $0 |
| Raphael Pascaud | CMO & Bus. Dev. | 1 października 2019 M | 27 156 | 0 | 0 | $0 |
| Julie Tay | SVP & Mng Dir. Asia Pacific | 8 maja 2019 S | 17 746 | 0 | 0 | $0 |
| Christopher C. Puco | VP, No. American Sales | 30 listopada 2018 S | 0 | 0 | 0 | $0 |
| Lynn Pendergrass | VP, Americas | 20 marca 2017 A | · | 0 | 0 | $0 |
| Timothy A Mack | VP, Bus Dev | 20 lutego 2016 M | 0 | 0 | 0 | $0 |
| Jennifer Erfurth | VP, Global HR | 20 lutego 2016 A | 10 760 | 0 | 0 | $0 |
| John Patrick Graham | VP, Mktg & CMO | 5 maja 2015 S | 0 | 0 | 0 | $0 |
| Richard M.L. Twomey | VP International | 30 października 2013 M | 4 272 | 0 | 0 | $0 |
| Dana Cambra | VP, R&D | 18 czerwca 2012 C | 4 398 | 0 | 0 | $0 |
| Sheila K Tan | VP Marketing & CMO | 17 listopada 2011 C | 19 523 | 0 | 0 | $0 |
| Afsaneh Azadeh | Chief Information Officer | 20 lutego 2008 A | · | 0 | 0 | $0 |
| Quentin S. Blackford | Dyrektor | 27 sierpnia 2026 A | · | 0 | 0 | $0 |
| Anne Myong | Dyrektor | 20 maja 2026 A | 9 830 | 0 | 0 | $0 |
| Mojdeh Poul | Dyrektor | 20 maja 2026 A | 3 553 | 0 | 0 | $0 |
| Kevin J Dallas | Dyrektor | 20 maja 2026 A | 16 168 | 0 | 0 | $0 |
| Britt J. Vitalone | Dyrektor | 20 maja 2026 A | 1 443 | 0 | 0 | $0 |
| Andrea Lynn Saia | Dyrektor | 20 maja 2026 A | 17 318 | 0 | 0 | $0 |
| Kevin T Conroy | Dyrektor | 20 maja 2026 A | 3 553 | 0 | 0 | $0 |
| Susan E Siegel | Dyrektor | 20 maja 2026 A | 10 723 | 0 | 0 | $0 |
| Joseph Lacob | Dyrektor | 20 maja 2026 A | 135 916 | 0 | 0 | $0 |
| MORROW GEORGE J | Dyrektor | 20 maja 2026 M | 5 036 | 0 | 0 | $0 |
| Raymond C Larkin JR | Dyrektor | 20 maja 2026 A | 27 454 | 0 | 0 | $0 |
| Warren S Thaler | Dyrektor | 17 maja 2023 M | 31 780 | 0 | 0 | $0 |
| Greg J Santora | Dyrektor | 17 maja 2023 M | 11 987 | 0 | 0 | $0 |
| Thomas M Prescott | Dyrektor | 19 maja 2021 M | 54 129 | 0 | 0 | $0 |
| David E Collins | Dyrektor | 15 maja 2014 C | 25 900 | 0 | 0 | $0 |
| Brian H Dovey | Dyrektor | 19 maja 2004 A | 0 | 0 | 0 | $0 |
| DANAHER CORP /DE/ | Posiadacz 10% | 13 listopada 2013 S | 3 837 132 | 0 | 0 | $0 |
| KLEINER PERKINS CAUFIELD & BYERS VIII LP | Posiadacz 10% | 10 listopada 2004 J | 1 492 421 | 0 | 0 | $0 |
| Roger E George | · | 14 maja 2019 S | 11 773 | 0 | 0 | $0 |
| David L White | · | 18 listopada 2016 G | 5 913 | 0 | 0 | $0 |
| David C Nagel | · | 13 maja 2016 M | 30 200 | 0 | 0 | $0 |
| Len Hedge | · | 20 lutego 2013 C | 55 861 | 0 | 0 | $0 |
| Dan Scott Ellis | · | 19 listopada 2012 M | 3 552 | 0 | 0 | $0 |
| Gil Laks | · | 24 lutego 2010 C | 9 773 | 0 | 0 | $0 |
| Sonia Clark | · | 25 września 2008 C | 1 806 | 0 | 0 | $0 |
| Darrell Zoromski | · | 20 sierpnia 2008 C | 1 647 | 0 | 0 | $0 |
| Kent H Bowen | · | 15 maja 2008 C | 84 500 | 0 | 0 | $0 |
| Hossein Arjomand | · | 26 listopada 2007 C | 617 | 0 | 0 | $0 |
| Eldon M Bullington | · | 26 listopada 2007 C | 4 967 | 0 | 0 | $0 |
| Michael J Henry | · | 1 maja 2007 S | 0 | 0 | 0 | $0 |
| Kelsey Wirth | · | 2 maja 2006 S | 1 074 022 | 0 | 0 | $0 |
| David Thrower | · | 10 sierpnia 2005 M | 15 980 | 0 | 0 | $0 |
| Brian Dovey | · | 25 maja 2005 A | · | 0 | 0 | $0 |
| Rok Sribar | · | 1 marca 2005 A | · | 0 | 0 | $0 |
| Robert D Mitchell | · | 22 lutego 2005 A | · | 0 | 0 | $0 |
| Patricia L Wadors | · | 22 lutego 2005 A | · | 0 | 0 | $0 |
| Cecilia Claudio | · | 22 lutego 2005 A | · | 0 | 0 | $0 |
| KPCB VIII ASSOCIATES LP | · | 10 listopada 2004 J | 86 526 | 0 | 0 | $0 |
| Amir Abolfathi | · | 8 listopada 2004 M | 10 334 | 0 | 0 | $0 |
| Jon Fjeld | · | 28 maja 2004 S | 108 864 | 0 | 0 | $0 |
| Gordon Gund | · | 10 maja 2004 P | 68 659 | 0 | 0 | $0 |
| Joe Breeland | · | 12 marca 2004 A | 53 985 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 89 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 3,44% | 9 273 NS | 31 lipca 2026 | N-PORT |
| PRNT · ARK ETF Trust | 1,58% | 5 467 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,55% | 96 243 SH | 23 października 2026 | Dziennie |
| RNIN · EA Series Trust | 1,09% | 11 732 NS | 31 lipca 2026 | N-PORT |
| ALTL · Pacer Funds Trust | 0,90% | 4 911 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0,85% | 52 527 NS | 31 lipca 2026 | N-PORT |
| SPHB · Invesco Exchange-Traded Fund Trust … | 0,75% | 38 658 SH | 23 października 2026 | Dziennie |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,70% | 376 NS | 31 lipca 2026 | N-PORT |
| HIBL · Direxion Shares ETF Trust | 0,61% | 2 712 NS | 31 lipca 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,55% | 723 SH | 23 października 2026 | Dziennie |
| PALC · Pacer Funds Trust | 0,52% | 6 492 NS | 31 lipca 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,45% | 5 971 NS | 31 sierpnia 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,28% | 10 766 NS | 31 lipca 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,28% | 235 486 NS | 31 lipca 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 30 473 NS | 31 lipca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,24% | 990 688 SH | 19 sierpnia 2026 | Dziennie |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1 283 452 SH | 23 października 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,17% | 204 512 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 32 382 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 0,16% | 39 100 SH | 11 września 2026 | Dziennie |
| ISCG · iShares Trust | 0,15% | 9 672 SH | 11 września 2026 | Dziennie |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,15% | 12 214 NS | 31 lipca 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,15% | 133 009 NS | 31 lipca 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,15% | 2 860 NS | 31 lipca 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1 921 NS | 31 lipca 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1 560 504 SH | 19 sierpnia 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,14% | 4 009 SH | 19 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,14% | 25 829 SH | 11 września 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,13% | 1 311 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 0,13% | 34 914 SH | 11 września 2026 | Dziennie |
| IWS · iShares Trust | 0,10% | 100 293 SH | 11 września 2026 | Dziennie |
| PEXL · Pacer Funds Trust | 0,10% | 295 NS | 31 lipca 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 4 998 SH | 23 października 2026 | Dziennie |
| WSML · iShares Trust | 0,10% | 4 205 SH | 11 września 2026 | Dziennie |
| RECS · Columbia ETF Trust I | 0,09% | 32 471 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,09% | 4 336 SH | 19 sierpnia 2026 | Dziennie |
| VFMF · VANGUARD WELLINGTON FUND | 0,08% | 3 482 SH | 19 sierpnia 2026 | Dziennie |
| IWR · iShares Trust | 0,07% | 274 791 SH | 11 września 2026 | Dziennie |
| XOEF · iShares Trust | 0,06% | 83 SH | 11 września 2026 | Dziennie |
| QARP · DBX ETF Trust | 0,05% | 227 NS | 31 sierpnia 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,04% | 424 NS | 31 lipca 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,04% | 18 NS | 31 sierpnia 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,04% | 15 374 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,04% | 1 211 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,04% | 4 965 NS | 31 lipca 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,03% | 417 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 96 570 NS | 31 lipca 2026 | N-PORT |
| IVE · iShares Trust | 0,03% | 111 147 SH | 11 września 2026 | Dziennie |
| IUSV · iShares Trust | 0,03% | 57 946 SH | 11 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 20 397 SH | 23 października 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,03% | 27 760 NS | 31 lipca 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 40 343 SH | 19 sierpnia 2026 | Dziennie |
| MNZL · EA Series Trust | 0,03% | 47 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,03% | 5 902 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,03% | 10 314 SH | 11 września 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 1 808 SH | 23 października 2026 | Dziennie |
| IWD · iShares Trust | 0,03% | 148 444 SH | 11 września 2026 | Dziennie |
| DEUS · DBX ETF Trust | 0,03% | 508 NS | 31 sierpnia 2026 | N-PORT |
| TILT · FlexShares Trust | 0,03% | 3 318 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,02% | 7 051 SH | 23 października 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,02% | 15 866 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,02% | 13 656 SH | 23 października 2026 | Dziennie |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 1 729 431 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 2 161 771 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 10 952 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 5 657 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,02% | 15 119 SH | 19 sierpnia 2026 | Dziennie |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,02% | 2 100 SH | 23 października 2026 | Dziennie |
| TOPC · iShares Trust | 0,02% | 40 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,02% | 21 777 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 3 372 NS | 31 lipca 2026 | N-PORT |
| XVV · iShares Trust | 0,02% | 762 SH | 11 września 2026 | Dziennie |
| SPUU · Direxion Shares ETF Trust | 0,02% | 251 NS | 31 lipca 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,02% | 1 595 NS | 31 lipca 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,02% | 396 SH | 23 października 2026 | Dziennie |
| IVV · iShares Trust | 0,02% | 839 331 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,01% | 46 084 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,01% | 18 798 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,01% | 2 819 SH | 11 września 2026 | Dziennie |
| HCMT · Direxion Shares ETF Trust | 0,01% | 464 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 87 429 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 53 SH | 23 października 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,01% | 5 207 NS | 31 lipca 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 58 076 SH | 19 sierpnia 2026 | Dziennie |
| LGDX · Tidal Trust III | 0,01% | 71 NS | 31 lipca 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,16% | -24 215 NS | 31 lipca 2026 | N-PORT |
| SLTY · Tidal Trust II | -2,76% | -3 000 NS | 31 lipca 2026 | N-PORT |
| ISCB · iShares Trust | · | 3 130 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 8 638 SH | 11 września 2026 | Dziennie |
ALGN Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
14 analityków · 2026-10-24Średnia cel $190.21 +23,1%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| MDLN | · | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Sygnał na żywo — jedyna wypełniona karta na ekranie.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.